ZURA Zura Bio Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: ZURA

Price (delayed)

$4.36

Market cap

$190.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.09

Enterprise value

$90.26M

zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven ...

Highlights
The debt has dropped by 100% year-on-year
The EPS has soared by 99% year-on-year and by 98% since the previous quarter
ZURA's net income has dropped by 135% year-on-year but it is up by 11% since the previous quarter
The quick ratio has declined by 19% since the previous quarter
The company's equity fell by 6% QoQ
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of ZURA
Market
Shares outstanding
43.59M
Market cap
$190.07M
Enterprise value
$90.26M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.2
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$60.36M
EBITDA
-$60.36M
Free cash flow
-$15.05M
Per share
EPS
-$2.09
Free cash flow per share
-$0.46
Book value per share
$1.36
Revenue per share
$0
TBVPS
$3.05
Balance sheet
Total assets
$100.84M
Total liabilities
$21.29M
Debt
$0
Equity
$59.33M
Working capital
$80.54M
Liquidity
Debt to equity
0
Current ratio
4.97
Quick ratio
4.92
Net debt/EBITDA
1.65
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-76.3%
Return on equity
-126.3%
Return on invested capital
N/A
Return on capital employed
-74.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZURA stock price

How has the Zura Bio stock price performed over time
Intraday
5.06%
1 week
20.44%
1 month
48.81%
1 year
-18.96%
YTD
-6.64%
QTD
69.65%

Financial performance

How have Zura Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$62.64M
Net income
-$60.36M
Gross margin
N/A
Net margin
N/A
ZURA's net income has dropped by 135% year-on-year but it is up by 11% since the previous quarter
The operating income has shrunk by 131% YoY but it rose by 9% QoQ

Growth

What is Zura Bio's growth rate over time

Valuation

What is Zura Bio stock price valuation
P/E
N/A
P/B
3.2
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 99% year-on-year and by 98% since the previous quarter
The price to book (P/B) is 9% less than the last 4 quarters average of 3.5
The company's equity fell by 6% QoQ

Efficiency

How efficient is Zura Bio business performance
The return on assets has dropped by 151% year-on-year but it is up by 40% since the previous quarter
Zura Bio's ROE has soared by 53% from the previous quarter

Dividends

What is ZURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ZURA.

Financial health

How did Zura Bio financials performed over time
The company's total liabilities rose by 44% YoY and by 12% QoQ
Zura Bio's current ratio has decreased by 19% QoQ
The debt is 100% smaller than the equity
The debt has dropped by 100% year-on-year
The debt to equity has surged by 100% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.